By Alex Boye
Chief Executive Officer (CEO) of The Diagnostic Herbal Industry, producers of Thorntina 74, Alex Osei Owusu, has underscored the need for scientists to shift their focus from researching into raw plants to already produced herbal medicines.
The Thorntina-74 producer believes that should scientists pay much attention to researching into already made herbal medicines they would be able to assist the Food and Drugs Authority (FDA) to sanitize the herbal medicine market and also give confidence to medical doctors to prescribe herbal drugs to their patients when the need be.
The CEO of the Diagnostic Herbal Industry made this known when he delivered a statement at the 7th International Society for Medicinal Plants and Environmental Development (SOMPED). 2023 conference held in Accra on Tuesday.
” if Scientists focus more on already produced herbal medicines, they will be able to discover more and further help the general public to understand why one herbal medicine is capable of treating more than one condition” he disclosed.
According to him, even though majority of herbal medicines are potent, doctors find it difficult to prescribe it for their patients since most of the practitioners are not scientists.
Mr. Owusu disabused the minds of Ghanaians who still doubt the efficacy of herbal medicine for curing multiple diseases and sickness to redirect their thoughts.
According to him, plants has broad-based compounds and when extracted, one herbal medicine may carry the potential of curing many diseases and sickness making some researchers and doctors doubt it efficacy.
According to him, unlike conventional medicine where the compounds are separated and focuses on one component for treating a particular disease or sickness, a herbal medicine can and has the potential for multiple cure.
“Going forward, the thoughts and strategies for research must change towards herbal product because many of these producers are traditional healers who lack the scientific knowledge to analyze the various compounds of their products,” Mr. Owusu stated.
He revealed that because herbal medicine producers lack the scientific knowledge to break the compounds and ingredients, it make registration difficult and cumbersome.
Mr. Owusu said “The onus lies on you (researchers) to assist FDA because as a regulator, they don’t have the time to go into the intricate of the product making registration very difficult”.
About Thorntina-74 Medicine;
The herbal immune booster, Thorntina 74 Mixture is aims at providing support for the immune system to fight infectious diseases, is a distillate generated from its three main plants (active ingredients).
The Thorntina74 has been for General Wellbeing.
